2025-10-08
32 分钟When it comes to women controlling their own economic destinies,
perhaps nothing has had a more profound impact than the contraceptive pill.
Indeed, you could argue that access to the pill has transformed entire economies.
But in the US, things might be on the cusp of change.
Earlier this year,
the Trump administration froze some federal funding for subsidized access to contraceptive services.
And that has made understanding the economic consequences of contraception all the more pressing.
Welcome to the Economic Show from the Financial Times.
I'm Sarah O'Connor, Employment Columnist here at the FT,
and today I'll be speaking with Martha Bailey.
Martha is a professor in the Department of Economics and Director of the California Center for Population Research at UCLA.
She's a leading figure in the study of American inequality and social policy.
Thank you for joining us, Martha.
Thanks for having me.
Now,
we often do this thing on the economic show where we begin by asking our guests to rate something on a scale of one to ten.
So my question to you,
the Trump administration appears to be walking back access to free birth control for some people on lower incomes.
How worried are you about the economic consequences of this on a scale where one is highly relaxed and ten is extremely concerned?
I would give that one a ten.